Context Therapeutics updates corporate presentation for investor meetings

Context Therapeutics Inc.

On August 7, 2023, Context Therapeutics updated its corporate presentation for use in investor meetings.
The presentation was filed as Exhibit 99.1 to Form 8-K.
The company's CEO Martin A. Lehr signed the filing.
The presentation includes information about advancing medicines for solid tumors.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.